Applied DNA Sciences (APDN)
(Delayed Data from NSDQ)
$0.54 USD
-0.01 (-0.94%)
Updated Jun 7, 2024 03:59 PM ET
After-Market: $0.53 -0.01 (-1.85%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth A Momentum B VGM
Brokerage Reports
Applied DNA Sciences Inc [APDN]
Reports for Purchase
Showing records 101 - 120 ( 165 total )
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Biotechnology: Invitation: Virtual 33rd Annual Roth Conference (March 15-17)
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Patent Issuance of Particular Relevance to Tagging Drugs & Nutraceuticals
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Signs Deal to Conduct COVID-19 Surveillance Testing for NYC''s LIM College
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Initiation of Coverage-Improving Therapeutics, Diagnostics,and Supply Chain Validation with PCR
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Biotech Should Keep the Wind at its Back in 2021; Top Healthcare Picks
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Equity Financing Completed; Reiterate Buy; Lowering PT to $14
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Linea COVID-19 Assay Distinguishes Mutant SARS-CoV-2; Raising PT to $18
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Preliminary F1Q21 Revenue Shows Significant Sequential Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Partnership to Expand Pooled COVID-19 Surveillance Testing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Fiscal Year 2020 Financial Results Reported; Reiterate Buy; Lowering PT to $12
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
COVID-19 Veterinary Vaccine Entering Feline Trial Soon; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
COVID-19 Kit EUA Amended; CLEP-CLIA Certification Delay; Reducing PT to $20
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Initial Stock Order Received for COVID-19 Surveillance Testing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
Capacity Expansion for COVID-19 Surveillance Testing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
COVID-19 Surveillance Testing Contracts Secured; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Applied DNA Sciences Inc
Industry: Security and Safety Services
COVID-19 Diagnostics Contract Inked With Academic Hospital; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y